Not provided
Not provided
Not provided
Not provided
Not enough of the screened participants met the inclusion criteria. Despite extensive recruitment efforts we could not recruit enough participants to reach the calculated target sample of 86 for randomization.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Linkoeping University | OTHER_GOV |
| Stockholm University | OTHER |
| Thomas More University of Applied Sciences | OTHER |
Not provided
Not provided
Not provided
Not provided
This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| One session therapy | Active Comparator | One session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand |
|
| One session therapy - divided into 3 | Experimental | Three session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety | Behavioral | A 3-hour one session exposure therapy for public speaking anxiety |
| Measure | Description | Time Frame |
|---|---|---|
| Public Speaking Anxiety Scale (PSAS), (Bartholomay & Houlihan, 2016). | Canonical total score will be used. Measure is self-rated, online. The scale consists of 17 self-report statements measured on a Likert-type scale ranging from 1 "not at all", to 5 "extremely". A higher score indicates higher levels of experienced public speaking anxiety. | Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Liebowitz Social Anxiety Scale - Self-Report (LSAS-SR), (Liebowitz, 2003; Rytwinski et al., 2009) | Canonical total score will be used. Measure is self-rated, online. Items are rated using 4-point Likert scales ranging from 0 to 3. A higher score indicates more severe symptoms. | Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Subjective Units of Distress (SUD) | Each measure will be rated on a scale from 0 to 100. Higher number indicates higher distress. | Pre-intervention, immediately after the intervention |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jonas Eimontas, PhD | Vilnius University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vilnius University | Vilnius | Lithuania | LT-01513 | Lithuania |
Following the publication of trial results, participant-level data without identifying information, i.e., anonymized, will be stored on a national data archive MIDAS and will be made available to researchers affiliated with research institutions upon a reasonable request. Statistical analysis procedures will be clearly defined in papers on trial results.
Following the publication of the trial results.
Available to researchers affiliated with research institutions upon a reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Brief Fear of Negative Evaluation Scale (BFNE), (Leary, 1983) | Canonical total score will be used. Measure is self-rated, online. The BFNE is a 12-item, 5-point Likert-type scale, ranging from 1 ""not at all" to 5 "extremely". Higher scores indicate higher fear. | Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment |
| Igroup Presence Questionnaire (IPQ) | Canonical total score will be used. Measure is self-rated, online. Each of the 14 items is rated on a 7-point Likert scale and the score is calculated by summing the ratings for each item. | Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment |
| Patient health questionnaire - 9 (PHQ-9), (Spitzer et al., 1999) | Canonical total score will be used. Measure is self-rated, online. PHQ-9 consists of 9 items that are rated depending on how often the symptoms were bothersome using a 4-point scale, ranging from 0 "not at all" to 3 "nearly every day". The ratings are summed for the total score and higher scores indicates more severe depression symtpoms. | Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment |